consent was provided by each subject. They were without gastrointestinal symptoms and had normal values for blood chemistry, haematology, and urinalysis. A physical examination and an electrocardiogram were normal. After an overnight fast (10.00 pm), an 18-gauge French double-lumen Salem tube was introduced into the stomach. The subjects were semi-reclined in a lounge chair for the rest of the study. The gastric contents were The subjects were divided into five groups, each group receiving a different dose of M-PGE.,. These doses were 10, 25, 50, 100, and 150 gg/subject. Each subject participated twice during the study, one day receiving placebo and the other day one of the doses of M-PGE. The two studies were separated by one week. The treatments were randomised and administered in a double-blind manner. M-PGE., was supplied as a solution of 250 sg/ml dissolved in triacetin, and diluted on the moLning of each study with water to a volume of 15 ml. sponse (Fig. 1) ISignificantly lower than mean acid secretion during placebo treatment P < 0-01.
+p< 05. The mean mmol of acid secreted per 15 minute time intervals for each group during two hours of meal stimulated intragastric titration. Acid secretion was measured by mmol of base (0-5 N NaOH) titrated to maintain intragastric pH constant at 5-5.
subject, or approximately 140 ng/kg. Although the total duration of action was not determined, as illustrated in Fig. 1 , it is clear that the antisecretory effect was near maximal, for each dose, for the 2' hours after administration of the prostaglandin, at which time the study was terminated.
As an indirect measure of gastric emptying, the amount of peptone meal that had to be administered to the volunteers 'to continue the intragastric titration was quantified. The nasogastric tube was placed in a dependent area of the stomach in all the volunteers. There was no statistical difference (P>0-05) in the amount of peptone meal that was added between the placebo and M-PGE, treated days, or between the different treatment groups.
No side-effects were observed except at the highest dose of 150 Mg; a,t that dose, three out of five subjects experienced loose stools later on the same day.
Discussion
This study shows that M-PGE, inhibits foodinduced gastric secretion a't extremely low doses. The compound is the most potent orally active an'tisecretory agent in man ever described. In view of this activity, and as methyl analogues of PGE, have been shown to inhibit formation of gastric and duodenal ulcers in animals,2 "' M-PGE2 would be expected to accelerate the healing rate of peptic ulcer in humans, and also to prevent ulcer recurrence. Two studies have shown that M-PGE2, or its methyl ester, given three to four times a day for two weeks, accelerated the healing rate of gastricl. and duodenalt-ulcers. In a multicentre study,
